Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Photobiomodulation for Cancer-Related Cognitive Impairment [NA]

View source ↗

Summary

Clinical trial update notes a study of photobiomodulation for cancer-related cognitive impairment, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Arash Asher, MD | Conditions: Cancer-related Cognitive Impairment | NA | Status: NOT_YET_RECRUITING